Minna Lehtisalo

3PUBLICATIONS
11CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Genomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 23, 2024
Ticagrelor modestly raises plasma riboflavin concentration in humans and inhibits riboflavin transport by BCRP and MRP4.

Feng Deng, Kreetta Hämäläinen, Minna Lehtisalo

|Oct 03, 2023
Ticagrelor Increases Exposure to the Breast Cancer Resistance Protein Substrate Rosuvastatin.

Minna Lehtisalo, E Katriina Tarkiainen, Mikko Neuvonen

|Aug 09, 2022
A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics.

Minna Lehtisalo, Suvi Taskinen, E Katriina Tarkiainen

Pageof 1